Search hospitals > Ohio > Toledo
Toledo Hospital
Claim this profileToledo, Ohio 43606
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Solid Tumors
Conducts research for Lymphoma
Conducts research for Cancer
260 reported clinical trials
4 medical researchers
Summary
Toledo Hospital is a medical facility located in Toledo, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Solid Tumors, Lymphoma, Cancer and other specialties. Toledo Hospital is involved with conducting 260 clinical trials across 250 conditions. There are 4 research doctors associated with this hospital, such as Michael Moront, MD, Mouhammad Jumaa, MD, Timothy Phelan, MD, and Kasi Ramanathan, MD.Area of expertise
1Breast Cancer
Global LeaderStage II
Stage I
Stage III
2Lung Cancer
Global LeaderTop PIs
Michael Moront, MDProMedica Toledo Hospital2 years of reported clinical research
Studies Aortic Valve Stenosis
Studies Aortic Stenosis
6 reported clinical trials
7 drugs studied
Mouhammad Jumaa, MDToledo Hospital3 years of reported clinical research
Studies Stroke
Studies Ischemic Stroke
6 reported clinical trials
8 drugs studied
Timothy Phelan, MDThe Toledo Hospital5 years of reported clinical research
Studies Heart Failure
Studies Congestive Heart Failure
1 reported clinical trial
2 drugs studied
Kasi Ramanathan, MDThe Toledo Hospital3 years of reported clinical research
Studies Stroke
Studies Bleeding
1 reported clinical trial
2 drugs studied
Clinical Trials running at Toledo Hospital
Stroke
Primary Hyperparathyroidism
Transient Ischemic Attack
Hyperparathyroidism
Hypercalcemia
Hip Fracture
Ischemia
Stroke Prevention
Ischemic Stroke
Brain Aneurysm
Asundexian
for Stroke Prevention
This trial is testing asundexian, a new medicine that prevents blood clots, in people who had a non-heart-related stroke or high-risk mini-stroke. The goal is to see if it works better at reducing future strokes without increasing bleeding risks. Asundexian is developed by Bayer AG and might prevent thrombosis without increasing bleeding.
Recruiting1 award Phase 3
Millipede System
for Ischemic Stroke
The objectives of the study are to examine the performance and safety characteristics of the Millipede System when used for revascularization of patients with acute ischemic stroke due to Large Vessel Occlusions (LVOs) and to record associated clinical outcomes.
Recruiting1 award N/A11 criteria
rFVIIa
for Hemorrhagic Stroke
The objective of the rFVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial is to establish the first treatment for acute spontaneous intracerebral hemorrhage (ICH) within a time window and subgroup of patients that is most likely to benefit. The central hypothesis is that rFVIIa, administered within 120 minutes from stroke onset with an identified subgroup of patients most likely to benefit, will improve outcomes at 180 days as measured by the Modified Rankin Score (mRS) and decrease ongoing bleeding as compared to standard therapy.
Recruiting1 award Phase 34 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Toledo Hospital?
Toledo Hospital is a medical facility located in Toledo, Ohio. This center is recognized for care of Breast Cancer, Lung Cancer, Solid Tumors, Lymphoma, Cancer and other specialties. Toledo Hospital is involved with conducting 260 clinical trials across 250 conditions. There are 4 research doctors associated with this hospital, such as Michael Moront, MD, Mouhammad Jumaa, MD, Timothy Phelan, MD, and Kasi Ramanathan, MD.